Skip Navigation Links.

Glaxosmithkline Pharma Ltd


BSE: 500660 | NSE: GLAXO | ISIN: INE159A01016 
Market Cap: [Rs.Cr.] 19,307 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Multinational

 Discuss this stock
2,279.502.05 (0.1%)
2,282.35-5.50 [0.2]%
BSE May 23,00:00
Day's High | Low 2,284.75 | 2,240.00
Day's Volumes 2,094
52Wk High | Low 2,522.00 | 1,916.00
Open Price 2,279.95
Turnover 4,734,041.00
Deliverable Vol. 1,454
6 Mth. Avg. Vol. 32,204.56
NSE May 23,00:00
Day's High | Low 2,317.90 | 2,244.10
Day's Volumes 6,798
52Wk High | Low 2,522.00 | 1,801.20
Open Price 2,317.90
Turnover 15,373,790.25
Deliverable Vol. 4,482
6 Mth. Avg. Vol. 69,246.02

May 23,2013 Open LTP Day's Range Volume
  2,317.90 2,282.35 2,317.90 - 2,244.10 6,798

Graph: Today |   1w |   1m |   3m |   6m |   1y |   3y Technical Charting  
IndiaInfoline
Make opportunities on the move…get daily stocks tips on your mobile.
Click here for details OR just SMS TIPS to 567675555

Key ratios

  Dec-12 Dec-11 Dec-10
P/E (x) 35.71 44.29 38.87
P/BV (x) 9.13 8.54 10.28
RONW (%) 34.3 30.7 30.6
ROCE (%) 45.2 45.1 45.5
EV/ EVBIDTA (x) 18.86 23.27 20.84
Dividend Yield (%) 2.2 2.2 2.2
APATM(%) 25.0 24.3 26.2
EPS 60.6 43.7 60.3

Shareholding Pattern

Particulars No. of
Shares(Mn) 		% Holdings
Total Promoter Holdings 42.92 50.7
Total Govt Holding (Promoter + Non Promoter) 0.00 0.0
Total Domestic Institutions (Banks/ FI + MF / UTI) 9.52 11.3
Total Foreign Holdings (FII+NRI holdings) 19.66 23.2
Total Non Promoter Corporate Holdings 0.68 0.8
Total Public & Others (Individuals + HUF + Clearing members) 11.92 14.0
Total 84.70 100
View detailed shareholding pattern next

Peer Comparison

Company Market Cap
(Rs. in Cr.) 		P/E (TTM)
(x) 		P/BV (TTM)
(x) 		EV/EBIDTA
(x) 		ROE
(%) 		ROCE
(%) 		D/E
(x)
Glaxosmit Pharma 19,307.37 29.17 9.61 18.86 34.3 45.2 0.00
Sanofi India 5,768.32 31.89 4.84 13.73 15.4 22.5 0.00
Pfizer 3,125.14 15.17 1.83 9.41 15.0 22.1 0.00
Abbott India 3,028.44 18.24 4.68 12.08 24.3 34.8 0.00
Fres.Kabi Onco. 1,974.34 22.01 3.33 22.38 3.5 5.4 0.42
Astrazeneca Phar 1,791.75 0.00 17.96 140.28 10.7 15.2 0.03
Wyeth 1,782.84 13.71 3.11 7.61 33.4 45.1 0.01
Novartis India 1,606.95 13.42 1.79 10.43 20.0 28.8 0.00
Merck 1,087.55 13.60 2.25 7.04 17.5 25.5 0.00
Fulford (India) 253.11 0.00 1.75 0.00 -3.4 -4.7 0.00
Organon (India) 159.14 0.00 0.98 0.00 15.3 22.8 0.00

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

D S Parekh , Chairman  

V Thyagarajan , Vice Chairman  

H B Joshipura , Managing Director  

R R Bajaaj , Director  

Company Head Office / Quarters:
GSK House,
Dr Annie Besant Road Worli,
Mumbai,
Maharashtra-400030
Phone : 91-022-24959595
Fax : 91-022-24959494
E-mail : ajay.a.nadkarni@gsk.com
Web : http://www.gsk-india.com
Registrars:
Karvy Computershare Pvt Ltd
Plot No 17-24
Vittal Rao Nagar
Madhapur
Hyderabad-500081

Calendar

May-2013
M T W T F S S
20 21 22 23 24 25 26
IPO
listIssue Opening : India Finsec
Economic Events
list Balance (YTD) (New Zealand dollars)
list Cap Goods Orders Nondef Ex Air
Results
list Britannia Inds. | Crompton Greaves | M R P L | Jet Airways